| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |